C. Olson

Capturing and Recreating Diverse Antibody Repertoires as Multivalent Recombinant Polyclonal Antibody Drugs

Robert C. Edgar, Heather E. Lynch, R. Edgar, 2020, bioRxiv.

GMP Manufacturing and IND-Enabling Studies of a Recombinant Hyperimmune Globulin Targeting SARS-CoV-2

R. Edgar, J. Simons, A. Adler, 2022, Pathogens.

Heterologous Vaccination with SARS-CoV-2 Spike saRNA Prime followed by DNA Dual-Antigen Boost Induces Robust Antibody and T-Cell Immunogenicity against both Wild Type and Delta Spike as well as Nucleocapsid Antigens

J. Safrit, Shiho Tanaka, A. Rice, 2021 .

Generation of recombinant hyperimmune globulins from diverse B-cell repertoires

Robert C. Edgar, Heather E. Lynch, R. Edgar, 2021, Nature Biotechnology.

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants

Shiho Tanaka, S. Rabizadeh, P. Soon-Shiong, 2021, Scientific Reports.